石莉,邓意辉,董晓辉,卢懿,周欣羽,王宁
SHI Li,DENG Yi-hui,DONG Xiao-hui,LU Yi,ZHOU Xin-yu,WANG Ning(School of Pharmacy

• 1:沈阳药科大学药学院

摘要(Abstract)：

目的建立一种不使用交联剂制备白蛋白纳米粒的新方法。方法以牛血清白蛋白(bovineserumalbumin,BSA)为材料,以本实验室合成的齐多夫定的前药—齐多夫定碳酸胆固醇酯(cholesteryl carbonate azidothymidine,AZTC)为主药,采用超声法制备齐多夫定碳酸胆固醇酯牛血清白蛋白(AZTC-BSA)纳米粒及其冻干制剂。以粒径为考察指标确定纳米粒的最佳处方及工艺;以冻干制剂外观、水化时间及复溶后粒径为考察指标确定冻干制剂的处方及工艺。结果成功制备了AZTC-BSA纳米粒,最佳超声时间为6 min,纳米粒平均粒径为137.9 nm,zeta电位为-54.6 mV,包封率为98.6%;冻干制剂外观良好,复溶后平均粒径为148.9 nm。结论超声法制备AZTC-BSA纳米粒新颖、简单、可靠。
Objective To prepare cholesteryl carbonate azidothymidine-bovine serum albumin(AZTC-BSA)nanoparticles by ultrasonication,and investigate the main factors in the process of preparing AZTC-BSA nanoparticles.Methods BSA as material,self-made AZTC which was the prodrug of AZT as the active component,AZTC-BSA nanoparticles and the freeze-dried formulations were successfully prepared by ultrasonication.The optimum formulation was selected through the mean particle size of AZTC-BSA nanopartilces.The appearance,rehydration time and particle size were also investigated to optimize the formulation of nanoparticles freeze-dried.Results The mean diameter of AZTC-BSA nanopartilces was 137.9 nm,the zeta potential was-54.6 mV,and the encapsulation efficiency was 98.6%.The mean diameter of nanopartilces freeze-dried with good appearance was 148.9 nm.Conclusions The technique of preparing AZTC-BSA nanoparticles with ultrasonication is simple,reliable and novel.

关键词(KeyWords)： 齐多夫定碳酸胆固醇酯;牛血清白蛋白;纳米粒;超声法;冻干保护剂;粒径分布
cholesteryl carbonate azidothymidine;bovine serum albumin;nanoparticle;ultrasonication;cryoprotectant;particle size distribution

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(30371694)

作者(Author): 石莉,邓意辉,董晓辉,卢懿,周欣羽,王宁
SHI Li,DENG Yi-hui,DONG Xiao-hui,LU Yi,ZHOU Xin-yu,WANG Ning(School of Pharmacy

参考文献(References)：

• [1]LANGTRY H D,CAMPOLI-RICHARDS D M.A re-view of its pharmacodynamic and pharmacokineticproperties,and therapeutic efficacy[J].Drugs,1989,37(4):408-450.
• [2]LI Xiao-ling,CHAN W K.Transport,metabolism andelimination mechanisms of anti-HIV agents[J].AdvDrug Deliv Rev,1999,39(1/2/3):81-103.
• [3]MONFARDINI C,VERONESE F M.Stabilization ofsubstances in circulation[J].Bioconjugate Chem,1998,9(4):418-450.
• [4]TORCHILIN V P,BERDICHEVSKY V R,BAR-SUKOV A A,et al.Coating liposomes with protein de-creased their capture by macrophages[J].FEBS Lett,1980,111(1):184-188.
• [5]LANGER K,ANHORN M G,STEINHAUSER I,etal.Human serum albumin(HSA)nanoparticles:Re-producibility of preparation process and kinetics of en-zymatic degradation[J].Int J Pharm,2008,347(1/2):109-117.
• [6]DREIS S,ROTHWEILER F,MICHAELIS M,et al.Preparation,characterisation and maintenance of drugefficacy of doxorubicin-loaded human serum albumin(HSA)nanoparticles[J].Int J Pharm,2007,341(1/2):207-214.
• [7]WARTLICK H,SCHMITT B S,STREBHARDT K,et al.Tumour cell delivery of antisense oligonucleotidesby human serum albumin nanoparticles[J].J ControlRelease,2004,96(3):483-495.
• [8]LANGER K,BALTHASAR S,VOGEL V,et al.Opti-mization of the preparation process for human serumalbumin(HSA)nanoparticles[J].Int J Pharm,2003,257(1/2):169-180.
• [9]王宁,邓意辉,王绍宁,等.高效液相色谱法测定葫芦素B人血清白蛋白纳米粒中药物含量[J].中国新药杂志,2007,16(23):1968-1970.
• [10]ZHANG Ling-ling,DENG Yi-hui,LI Yi,et al.Investi-gation of the pharmacokinetics and determination ofcholesteryl carbonate zidovudine in rat plasma by non-aqueous reversed-phase high performance liquid chro-matography with UV detection[J].J Chromatogr B,2007,853(1/2):163-167.
• [11]MILLER D P,ANDRESON R E,DE PABLO J J.Stabilization of lactate dehydrogenase following freeze-thawing and vacuum-drying in the presence of tre-halose and borate[J].Pharm Res,1998,15(8):1215-1221.